The month of March saw many firsts in terms of new drug approvals. So far this year, 8 novel drugs have been approved. Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before. Now, let's take a look at the biotech stocks awaiting FDA decision in April.
The proportion of women declines at each stage of executive career paths and they continue to be under-represented in senior leadership positions.
The unfolding week brings with it a host of Fed speeches as the quiet period ahead of the FOMC meeting expires. Traders can look ahead to explanations on the week’s policy move from these speeches.
Seven out of ten buildings are located in a sparkling new business cluster, symbolizing the resurgence of one former superpower.